ES556685A0 - Un procedimiento para preparar tioesteroides sustituidos en posicion 21 - Google Patents

Un procedimiento para preparar tioesteroides sustituidos en posicion 21

Info

Publication number
ES556685A0
ES556685A0 ES556685A ES556685A ES556685A0 ES 556685 A0 ES556685 A0 ES 556685A0 ES 556685 A ES556685 A ES 556685A ES 556685 A ES556685 A ES 556685A ES 556685 A0 ES556685 A0 ES 556685A0
Authority
ES
Spain
Prior art keywords
sup
group
carbon atoms
thyosteroids
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556685A
Other languages
English (en)
Other versions
ES8707256A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of ES8707256A1 publication Critical patent/ES8707256A1/es
Publication of ES556685A0 publication Critical patent/ES556685A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dowels (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES556685A 1985-06-26 1986-06-25 Un procedimiento para preparar tioesteroides sustituidos en posicion 21 Expired ES8707256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13927685 1985-06-26

Publications (2)

Publication Number Publication Date
ES8707256A1 ES8707256A1 (es) 1987-07-16
ES556685A0 true ES556685A0 (es) 1987-07-16

Family

ID=15241512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556685A Expired ES8707256A1 (es) 1985-06-26 1986-06-25 Un procedimiento para preparar tioesteroides sustituidos en posicion 21

Country Status (6)

Country Link
US (1) US4861765A (es)
EP (1) EP0208202B1 (es)
JP (1) JPH0699468B2 (es)
AT (1) ATE42306T1 (es)
DE (1) DE3662896D1 (es)
ES (1) ES8707256A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
AU2001275760B2 (en) * 2000-08-05 2005-03-17 Glaxo Group Limited 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP1587818A4 (en) 2003-01-21 2010-10-13 Merck Sharp & Dohme 17-CARBAMOYLOXY CORTISOL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2009085880A2 (en) * 2007-12-21 2009-07-09 Schering Corporation C-21 thioethers as glucocorticoid receptor agonists
CL2008003803A1 (es) * 2007-12-21 2010-02-19 Schering Corp Compuestos derivados de esteroides c20-21 sustituidos, agonistas del receptor de glucocorticoide; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar o prevenir una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como colitis inflamatoria y artritis reumatoide.
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規［３，２−ｃ］ヘテロアリールステロイド、組成物およびこの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028400A (en) * 1962-04-03 Nsw steroid thioethers and process
US3105083A (en) * 1960-04-14 1963-09-24 Upjohn Co 21-organic sulfonates of 11, 17, 21-trioxygenated-3-keto pregnenes
US3171844A (en) * 1963-05-24 1965-03-02 Syntex Corp 20-(aliphatic hydrocarbonthio) and 20-(substituted aliphatic hydrocarbonthio) pregnane derivatives
FR2231374B1 (es) * 1973-05-30 1976-10-22 Jouveinal Sa
ZA81976B (en) * 1980-02-15 1982-07-28 Glaxo Group Ltd Androstane carbothioates
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
FR2551069B1 (fr) * 1983-08-26 1986-07-25 Jouveinal Sa 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament
US4488995A (en) * 1984-02-06 1984-12-18 E. R. Squibb & Sons, Inc. Androstene-17β-alkylthiomethyl ethers

Also Published As

Publication number Publication date
DE3662896D1 (en) 1989-05-24
JPH0699468B2 (ja) 1994-12-07
ES8707256A1 (es) 1987-07-16
EP0208202B1 (en) 1989-04-19
JPS6289694A (ja) 1987-04-24
ATE42306T1 (de) 1989-05-15
US4861765A (en) 1989-08-29
EP0208202A1 (en) 1987-01-14

Similar Documents

Publication Publication Date Title
ES556685A0 (es) Un procedimiento para preparar tioesteroides sustituidos en posicion 21
ES545250A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
IE851205L (en) Beta-carbolines
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
ES511753A0 (es) Un procedimiento para la preparacion de derivados de sucrosa'4-halo-sustituidos.
ES544919A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes
GB8526612D0 (en) Diphenyl ether derivatives
DE3569380D1 (en) Pyridylphenylpyridazinone inotropic agents
ATE21902T1 (de) 6-substituierte tetrahydroimidazo(2,1a)phthalazine.
ES553166A0 (es) Un procedimiento para preparar un derivado de carbaciclina
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
DE3564937D1 (en) Novel substituted phenyl ethers, process for their preparation, and their use in the preparation of substituted phenols
ES8405033A1 (es) Procedimiento para la obtencion de esteroides dihalogenados.
HUT38948A (en) Process for preparing new isoxazolo-quinolinone derivatives and pharmaceutical compositions containing such compounds
ES8702350A1 (es) Procedimiento para la preparacion de nuevos derivados de benzoquinona
ATE28628T1 (de) Phenylethylaminderivate und ihre zwischenprodukte.
ES8702877A1 (es) Un metodo para producir un derivado de acido benzoico.
IT8340072A0 (it) Utensile composto per rotore di zappatrice, con piastra di blocco dell'utensile radiale
DK242483A (da) Fremgangsmaade til fremstilling af oximderivater af 7-aminothiazolylacetamidocephalosporansyre

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970701